← Back to Search

Other

Sunflower Lecithin for Meibomian Gland Dysfunction

N/A
Waitlist Available
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial studies how sunflower lecithin affects dry eye symptoms in adults.

Eligible Conditions
  • Meibomian Gland Dysfunction
  • Dry Eye Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline of the SPEED questionnaire score at Day 90
Secondary outcome measures
Change from Baseline of Fluorescein Tear Break-Up Time (Seconds) at Day 90
Change in number of MMP-positive eyes at Day 90
Least Squares Mean Change from Baseline in Meibomian Gland Score (MGS) at Day 90

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Sunflower LecithinExperimental Treatment1 Intervention
Total 4800 mg sunflower lecithin per day taken in 4 softgel capsules
Group II: Olive OilPlacebo Group1 Intervention
Total 4000 mg olive oil per day taken in 4 softgel capsules
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sunflower lecithin
2023
N/A
~40

Find a Location

Who is running the clinical trial?

Virginia Lions Institute FoundationUNKNOWN
George Washington UniversityLead Sponsor
243 Previous Clinical Trials
453,216 Total Patients Enrolled
David Belyea, MDStudy ChairThe George Washington University
1 Previous Clinical Trials
81 Total Patients Enrolled
~16 spots leftby Jun 2025